WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H407360
CAS#: 86690-14-4
Description: Halenaquinone is a phosphatidylinositol 3-kinase inhibitor, was isolated from the marine sponge Petrosia alfiani. Halenaquinone inhibits RANKL-induced osteoclastogenesis. Halenaquinone specifically inhibits the secondary DNA binding of RAD51. Halenaquinone induces apoptosis in PC12 cells.
Hodoodo Cat#: H407360
Name: Halenaquinone
CAS#: 86690-14-4
Chemical Formula: C20H12O5
Exact Mass: 332.07
Molecular Weight: 332.311
Elemental Analysis: C, 72.29; H, 3.64; O, 24.07
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Halenaquinone
IUPAC/Chemical Name: (S)-12b-methyl-1H-tetrapheno[5,4-bc]furan-3,6,8,11(2H,12bH)-tetraone
InChi Key: SMGBXXZKAPMTBB-FQEVSTJZSA-N
InChi Code: InChI=1S/C20H12O5/c1-20-5-4-16(23)12-8-25-19(17(12)20)18(24)11-6-9-10(7-13(11)20)15(22)3-2-14(9)21/h2-3,6-8H,4-5H2,1H3/t20-/m0/s1
SMILES Code: O=C1CC[C@@]2(C)C3=CC4=C(C(C=CC4=O)=O)C=C3C(C5=C2C1=CO5)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 332.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Tsukamoto S, Takeuchi T, Kawabata T, Kato H, Yamakuma M, Matsuo K, El-Desoky AH, Losung F, Mangindaan RE, de Voogd NJ, Arata Y, Yokosawa H. Halenaquinone inhibits RANKL-induced osteoclastogenesis. Bioorg Med Chem Lett. 2014 Nov 15;24(22):5315-7. doi: 10.1016/j.bmcl.2014.09.043. PubMed PMID: 25278237.
2: Takaku M, Kainuma T, Ishida-Takaku T, Ishigami S, Suzuki H, Tashiro S, van Soest RW, Nakao Y, Kurumizaka H. Halenaquinone, a chemical compound that specifically inhibits the secondary DNA binding of RAD51. Genes Cells. 2011 Apr;16(4):427-36. doi: 10.1111/j.1365-2443.2011.01494.x. PubMed PMID: 21375680.
3: Shih SP, Lee MG, El-Shazly M, Juan YS, Wen ZH, Du YC, Su JH, Sung PJ, Chen YC, Yang JC, Wu YC, Lu MC. Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities. Mar Drugs. 2015 May 20;13(5):3132-53. doi: 10.3390/md13053132. PubMed PMID: 26006712; PubMed Central PMCID: PMC4446623.
4: Wang J, Bourguet-Kondracki ML, Longeon A, Dubois J, Valentin A, Copp BR. Chemical and biological explorations of the electrophilic reactivity of the bioactive marine natural product halenaquinone with biomimetic nucleophiles. Bioorg Med Chem Lett. 2011 Feb 15;21(4):1261-4. doi: 10.1016/j.bmcl.2010.12.056. PubMed PMID: 21256013.
5: Longeon A, Copp BR, Roué M, Dubois J, Valentin A, Petek S, Debitus C, Bourguet-Kondracki ML. New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia. Bioorg Med Chem. 2010 Aug 15;18(16):6006-11. doi: 10.1016/j.bmc.2010.06.066. PubMed PMID: 20634081.
6: Kienzler MA, Suseno S, Trauner D. Vinyl quinones as Diels-Alder dienes: concise synthesis of (-)-halenaquinone. J Am Chem Soc. 2008 Jul 9;130(27):8604-5. doi: 10.1021/ja8035042. PubMed PMID: 18549215.
7: Fujiwara H, Matsunaga K, Saito M, Hagiya S, Furukawa K, Nakamura H, Ohizumi Y. Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells. Eur J Pharmacol. 2001 Feb 9;413(1):37-45. PubMed PMID: 11173061.
8: Cao S, Foster C, Brisson M, Lazo JS, Kingston DG. Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp. Bioorg Med Chem. 2005 Feb 15;13(4):999-1003. PubMed PMID: 15670907.
9: Sutherland HS, Souza FE, Rodrigo RG. A short synthesis of (+/-)-halenaquinone. J Org Chem. 2001 May 18;66(10):3639-41. PubMed PMID: 11348164.
10: Bae MA, Tsuji T, Kondo K, Hirase T, Ishibashi M, Shigemori H, Kobayashi J. Inhibition of Mammalian Topoisomerase I by Xestoquinone and Halenaquinone. Biosci Biotechnol Biochem. 1993 Jan;57(2):330-1. doi: 10.1271/bbb.57.330. PubMed PMID: 27314795.
11: Wakefield B, Halter RJ, Wipf P. Synthesis of (+/-)-thiohalenaquinone by iterative metalations of thiophene. Org Lett. 2007 Aug 2;9(16):3121-4. PubMed PMID: 17630756.
12: Nakamura M, Kakuda T, Qi J, Hirata M, Shintani T, Yoshioka Y, Okamoto T, Oba Y, Nakamura H, Ojika M. Novel relationship between the antifungal activity and cytotoxicity of marine-derived metabolite xestoquinone and its family. Biosci Biotechnol Biochem. 2005 Sep;69(9):1749-52. PubMed PMID: 16195594.
13: Lee RH, Slate DL, Moretti R, Alvi KA, Crews P. Marine sponge polyketide inhibitors of protein tyrosine kinase. Biochem Biophys Res Commun. 1992 Apr 30;184(2):765-72. PubMed PMID: 1315532.